▶ 調査レポート

血清学的移植診断の世界市場(~2026年)

• 英文タイトル:Global Serological Transplant Diagnostics Market Size, Status and Forecast 2020-2026

QYResearchが調査・発行した産業分析レポートです。血清学的移植診断の世界市場(~2026年) / Global Serological Transplant Diagnostics Market Size, Status and Forecast 2020-2026 / MRC2-11QY04587資料のイメージです。• レポートコード:MRC2-11QY04587
• 出版社/出版日:QYResearch / 2020年11月20日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、130ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:ヘルスケア
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Multi User¥865,800 (USD5,850)▷ お問い合わせ
  Enterprise License¥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料は血清学的移植診断のグローバル市場について調査・分析したレポートです。種類別(腎臓移植、肝移植、心臓移植、肺移植、膵臓移植)市場規模、用途別(病院、血液銀行、移植センター、ドナーレジストリおよび研究所)市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別血清学的移植診断の競争状況、市場シェア
・世界の血清学的移植診断市場:種類別市場規模 2015年-2020年(腎臓移植、肝移植、心臓移植、肺移植、膵臓移植)
・世界の血清学的移植診断市場:種類別市場規模予測 2021年-2026年(腎臓移植、肝移植、心臓移植、肺移植、膵臓移植)
・世界の血清学的移植診断市場:用途別市場規模 2015年-2020年(病院、血液銀行、移植センター、ドナーレジストリおよび研究所)
・世界の血清学的移植診断市場:用途別市場規模予測 2021年-2026年(病院、血液銀行、移植センター、ドナーレジストリおよび研究所)
・北米の血清学的移植診断市場分析:米国、カナダ
・ヨーロッパの血清学的移植診断市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの血清学的移植診断市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の血清学的移植診断市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの血清学的移植診断市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Bio-Rad Laboratories、Immucor、Siemens Healthineers、Ortho Clinical Diagnostics、Thermo Fisher Scientific、Agena Bioscience、AVIOQ、BAG Healthcare、BD、Beckman Coulter、Biogenuix、DIAGAST、Grifols、Hemo bioscience、Institut de Biotechnologies、Lorne Laboratories、MTC Invitro、Quotient Biodiagnostics、Tulip Group
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Serological transplant diagnostics are used for all types of transplants. The products are developed based on the agglutination and complement fixation technology.
Chronic kidney disease increases the risk of cardiovascular disease (CVD) and end-stage kidney renal disease (ESRD). The recent years witnessed a rise in the number of kidney transplantation procedures. The reduction in the average cost of gene sequencing will positively influence the growth of the human leukocyte antigen (HLA) typing market in the kidney transplantation segment. Additionally, the emergence of advanced serological diagnostic technologies will also boost the adoption of kidney transplantation procedures and will aid in serological transplant diagnostics market growth.

Market Analysis and Insights: Global Serological Transplant Diagnostics Market
The global Serological Transplant Diagnostics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Serological Transplant Diagnostics Scope and Market Size
Serological Transplant Diagnostics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Serological Transplant Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Bio-Rad Laboratories
Immucor
Siemens Healthineers
Ortho Clinical Diagnostics
Thermo Fisher Scientific
Agena Bioscience
AVIOQ
BAG Healthcare
BD
Beckman Coulter
Biogenuix
DIAGAST
Grifols
Hemo bioscience
Institut de Biotechnologies
Lorne Laboratories
MTC Invitro
Quotient Biodiagnostics
Tulip Group

Market segment by Type, the product can be split into
Kidney Transplantation
Liver Transplantation
Heart Transplantation
Lung Transplantation
Pancreas Transplantation
Market segment by Application, split into
Hospitals, Blood Banks, and Transplant Centers
Donor Registries and Research Laboratories

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Serological Transplant Diagnostics Revenue
1.4 Market by Type
1.4.1 Global Serological Transplant Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Kidney Transplantation
1.4.3 Liver Transplantation
1.4.4 Heart Transplantation
1.4.5 Lung Transplantation
1.4.6 Pancreas Transplantation
1.5 Market by Application
1.5.1 Global Serological Transplant Diagnostics Market Share by Application: 2020 VS 2026
1.5.2 Hospitals, Blood Banks, and Transplant Centers
1.5.3 Donor Registries and Research Laboratories
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Serological Transplant Diagnostics Market Perspective (2015-2026)
2.2 Global Serological Transplant Diagnostics Growth Trends by Regions
2.2.1 Serological Transplant Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Serological Transplant Diagnostics Historic Market Share by Regions (2015-2020)
2.2.3 Serological Transplant Diagnostics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Serological Transplant Diagnostics Market Growth Strategy
2.3.6 Primary Interviews with Key Serological Transplant Diagnostics Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Serological Transplant Diagnostics Players by Market Size
3.1.1 Global Top Serological Transplant Diagnostics Players by Revenue (2015-2020)
3.1.2 Global Serological Transplant Diagnostics Revenue Market Share by Players (2015-2020)
3.1.3 Global Serological Transplant Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Serological Transplant Diagnostics Market Concentration Ratio
3.2.1 Global Serological Transplant Diagnostics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Serological Transplant Diagnostics Revenue in 2019
3.3 Serological Transplant Diagnostics Key Players Head office and Area Served
3.4 Key Players Serological Transplant Diagnostics Product Solution and Service
3.5 Date of Enter into Serological Transplant Diagnostics Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Serological Transplant Diagnostics Historic Market Size by Type (2015-2020)
4.2 Global Serological Transplant Diagnostics Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Serological Transplant Diagnostics Market Size by Application (2015-2020)
5.2 Global Serological Transplant Diagnostics Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Serological Transplant Diagnostics Market Size (2015-2020)
6.2 Serological Transplant Diagnostics Key Players in North America (2019-2020)
6.3 North America Serological Transplant Diagnostics Market Size by Type (2015-2020)
6.4 North America Serological Transplant Diagnostics Market Size by Application (2015-2020)

7 Europe
7.1 Europe Serological Transplant Diagnostics Market Size (2015-2020)
7.2 Serological Transplant Diagnostics Key Players in Europe (2019-2020)
7.3 Europe Serological Transplant Diagnostics Market Size by Type (2015-2020)
7.4 Europe Serological Transplant Diagnostics Market Size by Application (2015-2020)

8 China
8.1 China Serological Transplant Diagnostics Market Size (2015-2020)
8.2 Serological Transplant Diagnostics Key Players in China (2019-2020)
8.3 China Serological Transplant Diagnostics Market Size by Type (2015-2020)
8.4 China Serological Transplant Diagnostics Market Size by Application (2015-2020)

9 Japan
9.1 Japan Serological Transplant Diagnostics Market Size (2015-2020)
9.2 Serological Transplant Diagnostics Key Players in Japan (2019-2020)
9.3 Japan Serological Transplant Diagnostics Market Size by Type (2015-2020)
9.4 Japan Serological Transplant Diagnostics Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Serological Transplant Diagnostics Market Size (2015-2020)
10.2 Serological Transplant Diagnostics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Serological Transplant Diagnostics Market Size by Type (2015-2020)
10.4 Southeast Asia Serological Transplant Diagnostics Market Size by Application (2015-2020)

11 India
11.1 India Serological Transplant Diagnostics Market Size (2015-2020)
11.2 Serological Transplant Diagnostics Key Players in India (2019-2020)
11.3 India Serological Transplant Diagnostics Market Size by Type (2015-2020)
11.4 India Serological Transplant Diagnostics Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Serological Transplant Diagnostics Market Size (2015-2020)
12.2 Serological Transplant Diagnostics Key Players in Central & South America (2019-2020)
12.3 Central & South America Serological Transplant Diagnostics Market Size by Type (2015-2020)
12.4 Central & South America Serological Transplant Diagnostics Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Bio-Rad Laboratories
13.1.1 Bio-Rad Laboratories Company Details
13.1.2 Bio-Rad Laboratories Business Overview
13.1.3 Bio-Rad Laboratories Serological Transplant Diagnostics Introduction
13.1.4 Bio-Rad Laboratories Revenue in Serological Transplant Diagnostics Business (2015-2020))
13.1.5 Bio-Rad Laboratories Recent Development
13.2 Immucor
13.2.1 Immucor Company Details
13.2.2 Immucor Business Overview
13.2.3 Immucor Serological Transplant Diagnostics Introduction
13.2.4 Immucor Revenue in Serological Transplant Diagnostics Business (2015-2020)
13.2.5 Immucor Recent Development
13.3 Siemens Healthineers
13.3.1 Siemens Healthineers Company Details
13.3.2 Siemens Healthineers Business Overview
13.3.3 Siemens Healthineers Serological Transplant Diagnostics Introduction
13.3.4 Siemens Healthineers Revenue in Serological Transplant Diagnostics Business (2015-2020)
13.3.5 Siemens Healthineers Recent Development
13.4 Ortho Clinical Diagnostics
13.4.1 Ortho Clinical Diagnostics Company Details
13.4.2 Ortho Clinical Diagnostics Business Overview
13.4.3 Ortho Clinical Diagnostics Serological Transplant Diagnostics Introduction
13.4.4 Ortho Clinical Diagnostics Revenue in Serological Transplant Diagnostics Business (2015-2020)
13.4.5 Ortho Clinical Diagnostics Recent Development
13.5 Thermo Fisher Scientific
13.5.1 Thermo Fisher Scientific Company Details
13.5.2 Thermo Fisher Scientific Business Overview
13.5.3 Thermo Fisher Scientific Serological Transplant Diagnostics Introduction
13.5.4 Thermo Fisher Scientific Revenue in Serological Transplant Diagnostics Business (2015-2020)
13.5.5 Thermo Fisher Scientific Recent Development
13.6 Agena Bioscience
13.6.1 Agena Bioscience Company Details
13.6.2 Agena Bioscience Business Overview
13.6.3 Agena Bioscience Serological Transplant Diagnostics Introduction
13.6.4 Agena Bioscience Revenue in Serological Transplant Diagnostics Business (2015-2020)
13.6.5 Agena Bioscience Recent Development
13.7 AVIOQ
13.7.1 AVIOQ Company Details
13.7.2 AVIOQ Business Overview
13.7.3 AVIOQ Serological Transplant Diagnostics Introduction
13.7.4 AVIOQ Revenue in Serological Transplant Diagnostics Business (2015-2020)
13.7.5 AVIOQ Recent Development
13.8 BAG Healthcare
13.8.1 BAG Healthcare Company Details
13.8.2 BAG Healthcare Business Overview
13.8.3 BAG Healthcare Serological Transplant Diagnostics Introduction
13.8.4 BAG Healthcare Revenue in Serological Transplant Diagnostics Business (2015-2020)
13.8.5 BAG Healthcare Recent Development
13.9 BD
13.9.1 BD Company Details
13.9.2 BD Business Overview
13.9.3 BD Serological Transplant Diagnostics Introduction
13.9.4 BD Revenue in Serological Transplant Diagnostics Business (2015-2020)
13.9.5 BD Recent Development
13.10 Beckman Coulter
13.10.1 Beckman Coulter Company Details
13.10.2 Beckman Coulter Business Overview
13.10.3 Beckman Coulter Serological Transplant Diagnostics Introduction
13.10.4 Beckman Coulter Revenue in Serological Transplant Diagnostics Business (2015-2020)
13.10.5 Beckman Coulter Recent Development
13.11 Biogenuix
10.11.1 Biogenuix Company Details
10.11.2 Biogenuix Business Overview
10.11.3 Biogenuix Serological Transplant Diagnostics Introduction
10.11.4 Biogenuix Revenue in Serological Transplant Diagnostics Business (2015-2020)
10.11.5 Biogenuix Recent Development
13.12 DIAGAST
10.12.1 DIAGAST Company Details
10.12.2 DIAGAST Business Overview
10.12.3 DIAGAST Serological Transplant Diagnostics Introduction
10.12.4 DIAGAST Revenue in Serological Transplant Diagnostics Business (2015-2020)
10.12.5 DIAGAST Recent Development
13.13 Grifols
10.13.1 Grifols Company Details
10.13.2 Grifols Business Overview
10.13.3 Grifols Serological Transplant Diagnostics Introduction
10.13.4 Grifols Revenue in Serological Transplant Diagnostics Business (2015-2020)
10.13.5 Grifols Recent Development
13.14 Hemo bioscience
10.14.1 Hemo bioscience Company Details
10.14.2 Hemo bioscience Business Overview
10.14.3 Hemo bioscience Serological Transplant Diagnostics Introduction
10.14.4 Hemo bioscience Revenue in Serological Transplant Diagnostics Business (2015-2020)
10.14.5 Hemo bioscience Recent Development
13.15 Institut de Biotechnologies
10.15.1 Institut de Biotechnologies Company Details
10.15.2 Institut de Biotechnologies Business Overview
10.15.3 Institut de Biotechnologies Serological Transplant Diagnostics Introduction
10.15.4 Institut de Biotechnologies Revenue in Serological Transplant Diagnostics Business (2015-2020)
10.15.5 Institut de Biotechnologies Recent Development
13.16 Lorne Laboratories
10.16.1 Lorne Laboratories Company Details
10.16.2 Lorne Laboratories Business Overview
10.16.3 Lorne Laboratories Serological Transplant Diagnostics Introduction
10.16.4 Lorne Laboratories Revenue in Serological Transplant Diagnostics Business (2015-2020)
10.16.5 Lorne Laboratories Recent Development
13.17 MTC Invitro
10.17.1 MTC Invitro Company Details
10.17.2 MTC Invitro Business Overview
10.17.3 MTC Invitro Serological Transplant Diagnostics Introduction
10.17.4 MTC Invitro Revenue in Serological Transplant Diagnostics Business (2015-2020)
10.17.5 MTC Invitro Recent Development
13.18 Quotient Biodiagnostics
10.18.1 Quotient Biodiagnostics Company Details
10.18.2 Quotient Biodiagnostics Business Overview
10.18.3 Quotient Biodiagnostics Serological Transplant Diagnostics Introduction
10.18.4 Quotient Biodiagnostics Revenue in Serological Transplant Diagnostics Business (2015-2020)
10.18.5 Quotient Biodiagnostics Recent Development
13.19 Tulip Group
10.19.1 Tulip Group Company Details
10.19.2 Tulip Group Business Overview
10.19.3 Tulip Group Serological Transplant Diagnostics Introduction
10.19.4 Tulip Group Revenue in Serological Transplant Diagnostics Business (2015-2020)
10.19.5 Tulip Group Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Serological Transplant Diagnostics Key Market Segments
Table 2. Key Players Covered: Ranking by Serological Transplant Diagnostics Revenue
Table 3. Ranking of Global Top Serological Transplant Diagnostics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Serological Transplant Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Kidney Transplantation
Table 6. Key Players of Liver Transplantation
Table 7. Key Players of Heart Transplantation
Table 8. Key Players of Lung Transplantation
Table 9. Key Players of Pancreas Transplantation
Table 10. Global Serological Transplant Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Serological Transplant Diagnostics Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Serological Transplant Diagnostics Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Serological Transplant Diagnostics Market Share by Regions (2015-2020)
Table 14. Global Serological Transplant Diagnostics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Serological Transplant Diagnostics Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Serological Transplant Diagnostics Market Growth Strategy
Table 20. Main Points Interviewed from Key Serological Transplant Diagnostics Players
Table 21. Global Serological Transplant Diagnostics Revenue by Players (2015-2020) (Million US$)
Table 22. Global Serological Transplant Diagnostics Market Share by Players (2015-2020)
Table 23. Global Top Serological Transplant Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Serological Transplant Diagnostics as of 2019)
Table 24. Global Serological Transplant Diagnostics by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Serological Transplant Diagnostics Product Solution and Service
Table 27. Date of Enter into Serological Transplant Diagnostics Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Serological Transplant Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 30. Global Serological Transplant Diagnostics Market Size Share by Type (2015-2020)
Table 31. Global Serological Transplant Diagnostics Revenue Market Share by Type (2021-2026)
Table 32. Global Serological Transplant Diagnostics Market Size Share by Application (2015-2020)
Table 33. Global Serological Transplant Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 34. Global Serological Transplant Diagnostics Market Size Share by Application (2021-2026)
Table 35. North America Key Players Serological Transplant Diagnostics Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Serological Transplant Diagnostics Market Share (2019-2020)
Table 37. North America Serological Transplant Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 38. North America Serological Transplant Diagnostics Market Share by Type (2015-2020)
Table 39. North America Serological Transplant Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 40. North America Serological Transplant Diagnostics Market Share by Application (2015-2020)
Table 41. Europe Key Players Serological Transplant Diagnostics Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Serological Transplant Diagnostics Market Share (2019-2020)
Table 43. Europe Serological Transplant Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Serological Transplant Diagnostics Market Share by Type (2015-2020)
Table 45. Europe Serological Transplant Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Serological Transplant Diagnostics Market Share by Application (2015-2020)
Table 47. China Key Players Serological Transplant Diagnostics Revenue (2019-2020) (Million US$)
Table 48. China Key Players Serological Transplant Diagnostics Market Share (2019-2020)
Table 49. China Serological Transplant Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 50. China Serological Transplant Diagnostics Market Share by Type (2015-2020)
Table 51. China Serological Transplant Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 52. China Serological Transplant Diagnostics Market Share by Application (2015-2020)
Table 53. Japan Key Players Serological Transplant Diagnostics Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Serological Transplant Diagnostics Market Share (2019-2020)
Table 55. Japan Serological Transplant Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Serological Transplant Diagnostics Market Share by Type (2015-2020)
Table 57. Japan Serological Transplant Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Serological Transplant Diagnostics Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Serological Transplant Diagnostics Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Serological Transplant Diagnostics Market Share (2019-2020)
Table 61. Southeast Asia Serological Transplant Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Serological Transplant Diagnostics Market Share by Type (2015-2020)
Table 63. Southeast Asia Serological Transplant Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Serological Transplant Diagnostics Market Share by Application (2015-2020)
Table 65. India Key Players Serological Transplant Diagnostics Revenue (2019-2020) (Million US$)
Table 66. India Key Players Serological Transplant Diagnostics Market Share (2019-2020)
Table 67. India Serological Transplant Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 68. India Serological Transplant Diagnostics Market Share by Type (2015-2020)
Table 69. India Serological Transplant Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 70. India Serological Transplant Diagnostics Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Serological Transplant Diagnostics Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Serological Transplant Diagnostics Market Share (2019-2020)
Table 73. Central & South America Serological Transplant Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Serological Transplant Diagnostics Market Share by Type (2015-2020)
Table 75. Central & South America Serological Transplant Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Serological Transplant Diagnostics Market Share by Application (2015-2020)
Table 77. Bio-Rad Laboratories Company Details
Table 78. Bio-Rad Laboratories Business Overview
Table 79. Bio-Rad Laboratories Product
Table 80. Bio-Rad Laboratories Revenue in Serological Transplant Diagnostics Business (2015-2020) (Million US$)
Table 81. Bio-Rad Laboratories Recent Development
Table 82. Immucor Company Details
Table 83. Immucor Business Overview
Table 84. Immucor Product
Table 85. Immucor Revenue in Serological Transplant Diagnostics Business (2015-2020) (Million US$)
Table 86. Immucor Recent Development
Table 87. Siemens Healthineers Company Details
Table 88. Siemens Healthineers Business Overview
Table 89. Siemens Healthineers Product
Table 90. Siemens Healthineers Revenue in Serological Transplant Diagnostics Business (2015-2020) (Million US$)
Table 91. Siemens Healthineers Recent Development
Table 92. Ortho Clinical Diagnostics Company Details
Table 93. Ortho Clinical Diagnostics Business Overview
Table 94. Ortho Clinical Diagnostics Product
Table 95. Ortho Clinical Diagnostics Revenue in Serological Transplant Diagnostics Business (2015-2020) (Million US$)
Table 96. Ortho Clinical Diagnostics Recent Development
Table 97. Thermo Fisher Scientific Company Details
Table 98. Thermo Fisher Scientific Business Overview
Table 99. Thermo Fisher Scientific Product
Table 100. Thermo Fisher Scientific Revenue in Serological Transplant Diagnostics Business (2015-2020) (Million US$)
Table 101. Thermo Fisher Scientific Recent Development
Table 102. Agena Bioscience Company Details
Table 103. Agena Bioscience Business Overview
Table 104. Agena Bioscience Product
Table 105. Agena Bioscience Revenue in Serological Transplant Diagnostics Business (2015-2020) (Million US$)
Table 106. Agena Bioscience Recent Development
Table 107. AVIOQ Company Details
Table 108. AVIOQ Business Overview
Table 109. AVIOQ Product
Table 110. AVIOQ Revenue in Serological Transplant Diagnostics Business (2015-2020) (Million US$)
Table 111. AVIOQ Recent Development
Table 112. BAG Healthcare Business Overview
Table 113. BAG Healthcare Product
Table 114. BAG Healthcare Company Details
Table 115. BAG Healthcare Revenue in Serological Transplant Diagnostics Business (2015-2020) (Million US$)
Table 116. BAG Healthcare Recent Development
Table 117. BD Company Details
Table 118. BD Business Overview
Table 119. BD Product
Table 120. BD Revenue in Serological Transplant Diagnostics Business (2015-2020) (Million US$)
Table 121. BD Recent Development
Table 122. Beckman Coulter Company Details
Table 123. Beckman Coulter Business Overview
Table 124. Beckman Coulter Product
Table 125. Beckman Coulter Revenue in Serological Transplant Diagnostics Business (2015-2020) (Million US$)
Table 126. Beckman Coulter Recent Development
Table 127. Biogenuix Company Details
Table 128. Biogenuix Business Overview
Table 129. Biogenuix Product
Table 130. Biogenuix Revenue in Serological Transplant Diagnostics Business (2015-2020) (Million US$)
Table 131. Biogenuix Recent Development
Table 132. DIAGAST Company Details
Table 133. DIAGAST Business Overview
Table 134. DIAGAST Product
Table 135. DIAGAST Revenue in Serological Transplant Diagnostics Business (2015-2020) (Million US$)
Table 136. DIAGAST Recent Development
Table 137. Grifols Company Details
Table 138. Grifols Business Overview
Table 139. Grifols Product
Table 140. Grifols Revenue in Serological Transplant Diagnostics Business (2015-2020) (Million US$)
Table 141. Grifols Recent Development
Table 142. Hemo bioscience Company Details
Table 143. Hemo bioscience Business Overview
Table 144. Hemo bioscience Product
Table 145. Hemo bioscience Revenue in Serological Transplant Diagnostics Business (2015-2020) (Million US$)
Table 146. Hemo bioscience Recent Development
Table 147. Institut de Biotechnologies Company Details
Table 148. Institut de Biotechnologies Business Overview
Table 149. Institut de Biotechnologies Product
Table 150. Institut de Biotechnologies Revenue in Serological Transplant Diagnostics Business (2015-2020) (Million US$)
Table 151. Institut de Biotechnologies Recent Development
Table 152. Lorne Laboratories Company Details
Table 153. Lorne Laboratories Business Overview
Table 154. Lorne Laboratories Product
Table 155. Lorne Laboratories Revenue in Serological Transplant Diagnostics Business (2015-2020) (Million US$)
Table 156. Lorne Laboratories Recent Development
Table 157. MTC Invitro Company Details
Table 158. MTC Invitro Business Overview
Table 159. MTC Invitro Product
Table 160. MTC Invitro Revenue in Serological Transplant Diagnostics Business (2015-2020) (Million US$)
Table 161. MTC Invitro Recent Development
Table 162. Quotient Biodiagnostics Company Details
Table 163. Quotient Biodiagnostics Business Overview
Table 164. Quotient Biodiagnostics Product
Table 165. Quotient Biodiagnostics Revenue in Serological Transplant Diagnostics Business (2015-2020) (Million US$)
Table 166. Quotient Biodiagnostics Recent Development
Table 167. Tulip Group Company Details
Table 168. Tulip Group Business Overview
Table 169. Tulip Group Product
Table 170. Tulip Group Revenue in Serological Transplant Diagnostics Business (2015-2020) (Million US$)
Table 171. Tulip Group Recent Development
Table 172. Research Programs/Design for This Report
Table 173. Key Data Information from Secondary Sources
Table 174. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Serological Transplant Diagnostics Market Share by Type: 2020 VS 2026
Figure 2. Kidney Transplantation Features
Figure 3. Liver Transplantation Features
Figure 4. Heart Transplantation Features
Figure 5. Lung Transplantation Features
Figure 6. Pancreas Transplantation Features
Figure 7. Global Serological Transplant Diagnostics Market Share by Application: 2020 VS 2026
Figure 8. Hospitals, Blood Banks, and Transplant Centers Case Studies
Figure 9. Donor Registries and Research Laboratories Case Studies
Figure 10. Serological Transplant Diagnostics Report Years Considered
Figure 11. Global Serological Transplant Diagnostics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Serological Transplant Diagnostics Market Share by Regions: 2020 VS 2026
Figure 13. Global Serological Transplant Diagnostics Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Serological Transplant Diagnostics Market Share by Players in 2019
Figure 16. Global Top Serological Transplant Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Serological Transplant Diagnostics as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Serological Transplant Diagnostics Revenue in 2019
Figure 18. North America Serological Transplant Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Serological Transplant Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Serological Transplant Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Serological Transplant Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Serological Transplant Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Serological Transplant Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Serological Transplant Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed